Addressing an intelligent question
I have received an email from a blog reader who asks an important, exigent question. She reports that she was initially diagnosed approximatedly 1 1/2 years ago with stage IV follicular lymphoma. Initial treatment was with Rituxan and CHOP as part of a clinical trial.
Now, there is evidence of relapse. The big question, "Should I look for another clinical trial?"
My response: While I am a great advocate of patient participation in clinical trials, I suggest that this patient obtain a consultation specifically related to radioimmunotherapy (RIT). Have the consultation with a radiation oncologist or nuclear medicine physician.
There is now sufficient data on the efficacy of RIT that this patient should---I would say, must---find out whether RIT is appropriate before entering another experimental trial.
Mort